Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

BBIOCRYST PHARMACEUTICALS INC

EconomyAI buildoutMarket MapFundsWatchlist
Log in
B

BIOCRYST PHARMACEUTICALS INC

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions

Loading earnings…

$8.78Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions
QuarterRevenue YoYGross marginCash & equivalents
QuarterRevenue YoYGross marginCash & equivalents
(Filed on August 5, 2026)
+33.6%98.2%$155M

Filing text is unavailable for this period.

(Filed on May 6, 2026)
+7.5%96.6%$171.6M

Filing text is unavailable for this period.

(Filed on February 26, 2026)
+209.1%97.7%$89.7M

Filing text is unavailable for this period.

(Filed on November 4, 2025)
+36.1%98.6%$84.1M

Filing text is unavailable for this period.

(Filed on August 5, 2026)
+49.4%98.3%$88M
(Filed on May 6, 2026)
+56.9%96.9%$105.2M
(Filed on February 26, 2026)
+40.8%95.4%$104.7M
(Filed on November 4, 2025)
+35.0%97.3%$96.8M
(Filed on August 5, 2025)
+32.5%98.4%$78.4M
(Filed on May 6, 2025)
+34.9%98.6%$84.3M
(Filed on February 25, 2025)
+17.4%98.3%$110.6M
(Filed on November 5, 2024)
+14.4%98.7%$150.9M
(Filed on August 6, 2024)
+25.9%98.9%$146.2M
(Filed on May 7, 2024)
+37.8%98.6%$155.1M
(Filed on February 27, 2024)
+68.7%97.0%$304.8M
(Filed on November 8, 2023)
+85.0%95.3%$246.9M
(Filed on August 7, 2023)
+31.2%99.6%$272.6M
(Filed on May 8, 2023)
+161.9%99.5%$395.5M
(Filed on February 27, 2023)
+1,074.3%99.1%$504.4M
(Filed on November 4, 2022)
+571.8%98.6%$199.6M
(Filed on August 5, 2022)
+1,640.1%99.4%$210.3M
(Filed on May 9, 2022)
+295.2%68.9%$226.9M
(Filed on February 28, 2022)
-89.9%99.2%$272.1M
(Filed on November 4, 2021)
+243.8%75.1%$96.5M
(Filed on August 9, 2021)
+98.3%100.0%$173.5M
(Filed on May 7, 2021)
-18.1%100.0%$101.9M
(Filed on March 1, 2021)
+1,355.7%94.1%$114.2M
(Filed on November 6, 2020)
+22.1%100.0%$29.9M
(Filed on August 10, 2020)
-88.4%100.0%$30.8M
(Filed on May 11, 2020)
+48.1%76.2%$34.8M
(Filed on March 13, 2020)
-29.8%—$26.7M
(Filed on November 8, 2019)
-83.4%—$52.6M
(Filed on August 8, 2019)
+303.2%—$27.1M
(Filed on May 9, 2019)
-57.9%—$43.8M
(Filed on March 14, 2019)
-56.7%100.0%$50.3M
(Filed on November 8, 2018)
+12.8%87.0%$117.8M
(Filed on August 9, 2018)
-35.3%—$39.7M
(Filed on May 9, 2018)
+95.8%—$75.2M
(Filed on March 12, 2018)
+95.2%—$22.1M
(Filed on November 8, 2017)
-29.3%—$35.4M
(Filed on August 8, 2017)
-81.5%—$8.7M
(Filed on May 8, 2017)
-29.4%—$12.9M
(Filed on February 27, 2017)
-15.5%99.8%$28.9M
(Filed on November 8, 2016)
+239.3%87.7%$46.6M
(Filed on August 8, 2016)
+1,662.8%—$76.8M
(Filed on May 9, 2016)
+97.4%99.8%$48.4M
(Filed on February 26, 2016)
-48.5%—$54.5M
(Filed on November 6, 2015)
+35.5%—$121.2M
(Filed on August 7, 2015)
+78.6%—$121.5M
(Filed on May 8, 2015)
-2.7%—$13.6M
(Filed on March 2, 2015)
+157.7%—$21.2M
(Filed on November 7, 2014)
-58.5%—$26.1M
(Filed on August 8, 2014)
-80.5%—$19.8M
(Filed on May 9, 2014)
-70.9%—$14.8M
(Filed on March 10, 2014)
-21.5%—$20.9M
(Filed on November 8, 2013)
+9.8%—$24M
(Filed on August 8, 2013)
+12.7%—$21.9M
(Filed on May 9, 2013)
+124.9%—$27.7M
(Filed on March 11, 2013)
-68.7%—$16.4M
(Filed on November 8, 2012)
-56.3%—$22.4M
(Filed on August 8, 2012)
-51.0%—$17M
(Filed on May 8, 2012)
———
(Filed on March 6, 2012)
—100.0%$13.6M
(Filed on November 3, 2011)
———
(Filed on August 4, 2011)
———